Kolexia
Lagrange Aurelie Oncologie médicale
Lagrange Aurelie
Oncologie médicale
Centre Georges-François Leclerc
Dijon, France
67 Activités
181 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Carcinomes Constipation Nausée COVID-19 Tumeurs du sein Vomissement

Collaborateurs

Voir plus
Favier Laure
Favier Laure
Centre Georges-François Leclerc, Dijon, France
Coudert Bruno
Coudert Bruno
Centre Georges-François Leclerc, Dijon, France
Kaderbhai Coureche Guillaume
Kaderbhai Coureche Guillaume
Centre Georges-François Leclerc, Dijon, France
Foucher Pascal
Foucher Pascal
Hôpital François Mitterrand, Dijon, France

Industries

Voir plus
AstraZeneca
10 collaboration(s)
Dernière en 2023
MSD
3 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
3 collaboration(s)
Dernière en 2023
A+A
2 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
PACT-01: Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.
Essai Clinique (Institut Curie)   29 janvier 2024
NIRVANA-LUNG: PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer
Essai Clinique (Unicancer)   11 décembre 2023
PREDIGOSTEO: Osteopathy and Prevention of Gastrointestinal Side Effects of the Adjuvant Treatment FEC in Women Treated in Day Hospital for Breast Cancer
Essai Clinique (Centre Georges-François Leclerc)   16 octobre 2023
1262MO Impact of a minimal versus CT-scan-based follow-up on patient-reported outcomes for completely resected non-small cell lung cancer (NSCLC) in phase III IFCT-0302 trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes.
Molecular cancer   29 juillet 2023
UCPVax: Anticancer Therapeutic Vaccination Using Telomerase-derives Universal Cancer Peptides in Metastatic Non Small Cell Lung Cancer : A Phase I/II Study
Essai Clinique (Invectys)   13 juillet 2023
Exome-Based Genomic Markers Could Improve Prediction of Checkpoint Inhibitor Efficacy Independently of Tumor Type.
International journal of molecular sciences   20 avril 2023
FRAIL-IMMUNE: Multicenter Prospective Single Arm Phase II Study Evaluating Efficacy & Safety of Durvalumab With Carboplatin/Paclitaxel as First Line Treatment in Patients With Recurrent/Metastatic SCCHN Not Eligible to Standard Chemotherapy
Essai Clinique (Centre Léon-Bérard)   03 octobre 2022
Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   07 septembre 2022
Uncommon EGFR mutations in lung carcinoma: features and treatment outcomes in a retrospective French cohort.
Journal of thoracic disease   16 juillet 2022